Letizia Goretti

Chief Executive Officer, Alia Therapeutics

Professional Overview

Letizia Goretti is a seasoned pharmaceutical executive with over 20 years of experience in the industry. As the Chief Executive Officer of Alia Therapeutics, she leverages her deep expertise in transactions, alliances, and new product development to drive the company's strategic initiatives and accelerate innovation in the field of therapeutic development.

Experience Summary

Current Role

As the Chief Executive Officer of Alia Therapeutics since May 2023, Letizia is responsible for setting the overall vision and strategic direction of the company. She oversees the development and execution of Alia's pipeline, fosters collaborative partnerships, and ensures the efficient and effective operations of the organization. Under her leadership, Alia Therapeutics is poised to make significant contributions to the advancement of novel therapeutic solutions.

Career Progression

Prior to her current role, Letizia held various leadership positions at prominent pharmaceutical companies. At Johnson & Johnson, she served as the Senior Director of Transactions & Alliances, where she played a pivotal role in managing strategic partnerships and driving business development initiatives. Before that, she held progressive roles at Janssen Europe, Middle East & Africa (EMEA), including Director of Life Cycle Management and Established Brands, as well as Director of Partnership Development and New Business Development. Earlier in her career, Letizia gained valuable experience in quality assurance and control at GlaxoWellcome and Bristol-Myers Squibb.

Academic Background

Letizia holds a Bachelor's degree in Pharmaceutical Sciences from the University of Florence, Italy. Her academic background has provided her with a solid foundation in the pharmaceutical industry and has equipped her with the scientific and technical expertise to navigate the complex landscape of drug development and commercialization.

Areas of Expertise

• Transactions and strategic alliances

• Life cycle management and new product development

• Pharmaceutical operations and quality assurance

• Business development and partnership management

• Therapeutic innovation and pipeline optimization

Professional Impact

Throughout her career, Letizia has demonstrated a track record of driving tangible results and making significant contributions to the pharmaceutical industry. Her expertise in transactions and alliances has enabled her to forge valuable partnerships, resulting in the successful introduction and commercialization of several innovative therapies. As a leader, Letizia has consistently fostered a culture of collaboration and innovation, empowering her teams to deliver transformative solutions that improve patient outcomes.

Conclusion

Letizia Goretti's extensive experience, coupled with her strategic vision and unwavering commitment to innovation, positions her as a highly respected and influential leader in the pharmaceutical industry. As the Chief Executive Officer of Alia Therapeutics, she is well-equipped to guide the company's growth, unlock new opportunities, and make a lasting impact on the lives of patients worldwide.